New therapy helps reduce hospitalization for COVID patients
Bamlanivimab is not easy to pronounce, but it’s a new therapy that helps prevent dangerous outcomes and hospitalizations for high-risk patients with COVID-19. And it has finally arrived in Texas. Jan Patterson, MD, said that "patients who are treated early could potentially be kept out of the hospital, especially the high-risk patients with obesity, diabetes, cardiovascular disease and immuno-suppressed patients."